COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Proof-of-concept Study to Assess the Efficacy and Safety of SRX246 in Adults With PTSD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02733614
Recruitment Status : Suspended (COVID-19)
First Posted : April 11, 2016
Last Update Posted : June 18, 2020
Weill Medical College of Cornell University
United States Department of Defense
U.S. Army Medical Research and Development Command
Information provided by (Responsible Party):
Azevan Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2021